These researchers further observed decreased expression of HOTAIR, bcl-2, and H19, along with overexpression of MEG3, after treating ovarian cancer cells with DNC (35), indicating that curcumin exerts its anticancer effects via multiple pathways. This evidence concerns the gene H19 and ovarian carcinoma.